253 related articles for article (PubMed ID: 32344943)
1. Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone.
Hwang J; Youn K; Ji Y; Lee S; Lim G; Lee J; Ho CT; Leem SH; Jun M
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32344943
[TBL] [Abstract][Full Text] [Related]
2. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
3. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
[TBL] [Abstract][Full Text] [Related]
5. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
Lee S; Youn K; Lim G; Lee J; Jun M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
[TBL] [Abstract][Full Text] [Related]
6. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
Atay MS; Sari S; Bodur E
Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
[TBL] [Abstract][Full Text] [Related]
10. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
11. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
Basiri A; Abd Razik BM; Ezzat MO; Kia Y; Kumar RS; Almansour AI; Arumugam N; Murugaiyah V
Bioorg Chem; 2017 Dec; 75():210-216. PubMed ID: 28987876
[TBL] [Abstract][Full Text] [Related]
13. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydroquinoline-Isoxazole/Isoxazoline Hybrid Compounds as Potential Cholinesterases Inhibitors: Synthesis, Enzyme Inhibition Assays, and Molecular Modeling Studies.
Rodríguez Núñez YA; Gutíerrez M; Alzate-Morales J; Adasme-Carreño F; Güiza FM; Bernal CC; Bohórquez ARR
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861333
[TBL] [Abstract][Full Text] [Related]
15. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
Abdullaha M; Nuthakki VK; Bharate SB
Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
[TBL] [Abstract][Full Text] [Related]
16. Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer's disease.
Tripathi MK; Sharma P; Tripathi A; Tripathi PN; Srivastava P; Seth A; Shrivastava SK
J Comput Aided Mol Des; 2020 Sep; 34(9):983-1002. PubMed ID: 32488355
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]